View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

FDA Finalizes Biosimilar Guidance

The Regulatory Affairs Professional Society (RAPS) has posted an informative article “After Three-Year Delay, FDA Finalizes Guidance Documents on Biosimilarity.”  The article includes links to the final guidance documents.

You can find the article here.

Share
WoessnerWarrenWebsite
Author:
Principal


  Back to All Resources